Towards Evidence-Based Management of Inherited Breast and Breast-Ovarian Cancer

par Møller Pål
Publié 2004-12-01

Towards Evidence-Based Management of Inherited Breast and Breast-Ovarian Cancer

par Møller, Pål
Publié 2004

The Prospective Lynch Syndrome Database reports enable evidence-based personal precision health care

par Møller, Pål
Publié dans Hered Cancer Clin Pract (2020)

The BRCA2 variant c.68-7 T>A is associated with breast cancer

par Møller, Pål, Hovig, Eivind
Publié dans Hered Cancer Clin Pract (2017)

Retraction Note to: The BRCA2 variant c.68–7 T > A is associated with breast cancer

par Møller, Pål, Hovig, Eivind
Publié dans Hered Cancer Clin Pract (2018)

Our genes, our selves: hereditary breast cancer and biological citizenship in Norway

par Møller, Pål, Hovig, Eivind
Publié dans Med Health Care Philos (2017)

Costs and Benefits of Diagnosing Familial Breast Cancer

par Heimdal, Ketil, Mæhle, Lovise, Møller, Pål
Publié 1999

MRI screening of women with hereditary predisposition to breast cancer: diagnostic performance and survival analysis

par Tharmaratnam, Kukatharmini, Hagen, Anne Irene, Møller, Pål
Publié dans Breast Cancer Res Treat (2014)

No Sib Pair Concordance for Breast or Ovarian Cancer in BRCA1 Mutation Carriers

par Møller, Pål, Mæhle, Lovise, Clark, Neal, Apold, Jaran
Publié 2007

Uptake of Genetic Testing and Pre-Test Levels of Mental Distress in Norwegian Families with Known BRCA1 Mutations

par Reichelt, Jon G., Dahl, Alv A., Heimdal, Ketil, Møller, Pål
Publié 1999

Causes for Frequent Pathogenic BRCA1 Variants Include Low Penetrance in Fertile Ages, Recurrent De-Novo Mutations and Genetic Drift

par Møller, Pål, Dominguez-Valentin, Mev, Rødland, Einar Andreas, Hovig, Eivind
Publié dans Cancers (Basel) (2019)

Correction: Møller, P.; et al. Causes for Frequent Pathogenic BRCA1 Variants Include Low Penetrance in Fertile Ages, Recurrent De-Novo Mutations and Genetic Drift. Cancers 2019, 11...

par Møller, Pål, Dominguez-Valentin, Mev, Rødland, Einar Andreas, Hovig, Eivind
Publié dans Cancers (Basel) (2020)

Prospective observational data informs understanding and future management of Lynch syndrome: insights from the Prospective Lynch Syndrome Database (PLSD)

par Seppälä, Toni T., Dominguez-Valentin, Mev, Sampson, Julian R., Møller, Pål
Publié dans Fam Cancer (2020)

MUTYH Mutations Do Not Cause HNPCC or Late Onset Familial Colorectal Cancer

par Stormorken, Astrid, Heintz, Karen-Marie, Andresen, Per Arne, Hovig, Eivind, Møller, Pål
Publié 2006

BRCA1 1675delA and 1135insA Account for One Third of Norwegian Familial Breast-Ovarian Cancer and Are Associated with Later Disease Onset than Less Frequent Mutations

par Borg, Åke, Dørum, Anne, Heimdal, Ketil, Mæhle, Lovise, Hovig, Eivind, Møller, Pål
Publié 1999

Survival in Norwegian BRCA1 mutation carriers with breast cancer

par Hagen, Anne Irene, Tretli, Steinar, Mæhle, Lovise, Apold, Jaran, Vedå, Nina, Møller, Pål
Publié 2009

Ten modifiers of BRCA1 penetrance validated in a Norwegian series

par Heramb, Cecilie, Ekstrøm, Per Olaf, Tharmaratnam, Kukatharmini, Hovig, Eivind, Møller, Pål, Mæhle, Lovise
Publié dans Hered Cancer Clin Pract (2015)

Germline PTEN mutations are rare and highly penetrant

par Rustad Cecilie F, Bjørnslett Merete, Heimdal Ketil R, Mæhle Lovise, Apold Jaran, Møller Pål
Publié 2006-12-01

Germline PTEN mutations are rare and highly penetrant

par Rustad, Cecilie F, Bjørnslett, Merete, Heimdal, Ketil R, Mæhle, Lovise, Apold, Jaran, Møller, Pål
Publié 2006

The clinical utility of genetic testing in breast cancer kindreds: a prospective study in families without a demonstrable BRCA mutation

par Møller, Pål, Stormorken, Astrid, Holmen, Marit Muri, Hagen, Anne Irene, Vabø, Anita, Mæhle, Lovise
Publié 2014